Ataxia-telangiectasia (A-T) is a rare, multisystem, progressive disorder caused by a genetic mutation, which causes a variety of different symptoms. It is believed to be the earliest feature of A-T is an increased sensitivity to radiation. Individuals with the disorder have an increased risk of developing cancer because of this increased sensitivity. Other early symptoms of A-T include poor balance and coordination, slurred speech, and a weakened immune system. As the condition progresses, individuals may experience more severe symptoms, such as muscle weakness, vision problems, and difficulty swallowing. Additionally, individuals with A-T may experience frequent infections, which can lead to further complications. As the disease progresses, individuals may experience difficulty with movement and coordination. In the most advanced stages of the disorder, individuals may experience difficulty with speech, swallowing, and breathing.
A-T is a rare disorder that is caused by a genetic mutation, and it is believed to be the earliest feature of the disorder is an increased sensitivity to radiation. This increased sensitivity can lead to an increased risk of developing cancer, as well as other symptoms such as poor balance and coordination, slurred speech, and a weakened immune system. As the condition progresses, individuals may experience more advanced symptoms, such as difficulty with movement, vision problems, and difficulty swallowing. Treatment for A-T is primarily supportive, and involves managing symptoms and providing care to help maintain quality of life.